Results 231 to 240 of about 24,387,293 (346)

Human plasma kallikrein processing: Proteolysis as an alternative control [PDF]

, 1992
Fink, Edwin, Motta, G., Sampaio, C. A. M., Sampaio, Misako U.   +3 more
core  

rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data

Proceedings of the National Academy of Sciences of the United States of America, 2014
Shihao Shen, J. Park, Zhi-xiang Lu, Lan Lin, M. Henry, Ying Nian Wu, Qing Zhou, Yi Xing   +7 more
semanticscholar   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II. [PDF]

PLoS One
Zhang J, Yu H, Yang Y, Liu A, Wang P.
europepmc   +1 more source

Insecticide resistance in the horn fly: alternative control strategies

Medical and Veterinary Entomology, 2008
M. P. Oyarzún, Andrés Quiroz, M. A. Birkett   +2 more
semanticscholar   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Evaluation of the Antimicrobial Efficacy of Sodium Hypochlorite, Ozone, Diode Laser, and Photodynamic Therapy Against Enterococcus faecalis and Streptococcus mutans: An In-Vitro Study. [PDF]

Oral Health Prev Dent
Ozkan C, Derelioglu SS, Hanci H, Ince NNA, Sengul F, Kaplan EBE, Celikel P.   +6 more
europepmc   +1 more source

Impact of Animal Disease Outbreaks and Alternative Control Practices on Agricultural Markets and Trade: The case of FMD

, 2009
F. Junker, J. Ilicic-Komorowska, F. V. Tongeren   +2 more
semanticscholar   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Multilayered Control of Alternative Splicing Regulatory Networks by Transcription Factors.

Molecules and Cells, 2017
H. Han, Ulrich Braunschweig, Thomas Gonatopoulos-Pournatzis, Robert J. Weatheritt, Calley L. Hirsch, Kevin C. H. Ha, Ernest Radovani, Syed Nabeel-Shah, Timothy Sterne-Weiler, Juli Wang, D. O’Hanlon, Q. Pan, D. Ray, Hong Zheng, F. Vizeacoumar, A. Datti, L. Magomedova, C. Cummins, T. Hughes, J. Greenblatt, J. Wrana, J. Moffat, B. Blencowe   +22 more
semanticscholar   +1 more source